Nanotechnology based advanced therapeutic strategies for targeting interleukins in chronic respiratory diseases
Both communicable and non-communicable chronic respiratory conditions have accorded
for suffering of millions of people of all ages and stated to be leading cause of death …
for suffering of millions of people of all ages and stated to be leading cause of death …
Conventional and nanotechnology based approaches to combat chronic obstructive pulmonary disease: implications for chronic airway diseases
M Passi, S Shahid, S Chockalingam… - International journal …, 2020 - Taylor & Francis
Chronic obstructive pulmonary disease (COPD) is the most prevalent obstructive lung
disease worldwide characterized by decline in lung function. It is associated with airway …
disease worldwide characterized by decline in lung function. It is associated with airway …
[HTML][HTML] Recent advances in nanoparticle applications in respiratory disorders: A Review
ME Taghavizadeh Yazdi, M Qayoomian… - Frontiers in …, 2023 - frontiersin.org
Various nanoparticles are used in the discovery of new nanomedicine to overcome the
shortages of conventional drugs. Therefore, this article presents a comprehensive and up-to …
shortages of conventional drugs. Therefore, this article presents a comprehensive and up-to …
Nano-based therapies for acute and chronic lung diseases
Nanotechnology in medicine—known as nanomedicine—has opened a new era for
accurate and precise diagnosis and treatment of pulmonary inflammatory diseases. This …
accurate and precise diagnosis and treatment of pulmonary inflammatory diseases. This …
Advancing of cellular signaling pathways in respiratory diseases using nanocarrier based drug delivery systems
Cell Signaling pathways form an integral part of our existence that allows the cells to
comprehend a stimulus and respond back. Such reactions to external cues from the …
comprehend a stimulus and respond back. Such reactions to external cues from the …
Nanocarrier-based approaches to combat chronic obstructive pulmonary disease
Abnormalities in airway mucus lead to chronic disorders in the pulmonary system such as
asthma, fibrosis and chronic obstructive pulmonary disease (COPD). Among these, COPD is …
asthma, fibrosis and chronic obstructive pulmonary disease (COPD). Among these, COPD is …
Emerging strategies in nanotechnology to treat respiratory tract infections: Realizing current trends for future clinical perspectives
M Chen, Z Shou, X Jin, Y Chen - Drug Delivery, 2022 - Taylor & Francis
A boom in respiratory tract infection cases has inflicted a socio-economic burden on the
healthcare system worldwide, especially in developing countries. Limited alternative …
healthcare system worldwide, especially in developing countries. Limited alternative …
Nanomedicines targeting respiratory injuries for pulmonary disease management
The respiratory system holds crucial importance in the biology of vertebrate animals. Injuries
of the respiratory system caused by viral infections (eg, by COVID‐19, MERS, and SARS) …
of the respiratory system caused by viral infections (eg, by COVID‐19, MERS, and SARS) …
New perspectives in nanotherapeutics for chronic respiratory diseases
Abstract According to the World Health Organization (WHO), hundreds of millions of people
of all ages and in all countries suffer from chronic respiratory diseases, with particular …
of all ages and in all countries suffer from chronic respiratory diseases, with particular …
[HTML][HTML] Nanomedicine and medicinal plants: emerging symbiosis in managing lung diseases and associated infections
Pulmonary diseases refer to a broad category of diseases (both acute and chronic) related
to the lungs that include asthma, acute lung injury, chronic obstructive pulmonary disease …
to the lungs that include asthma, acute lung injury, chronic obstructive pulmonary disease …